Every living creature on Earth needs to protect itself from things that would do it harm. Bacteria are no different. And ...

CRISPR Therapeutics is paying $25 million upfront to work on multiple siRNA targets with Sirius Tx with an early focus on the ...

Swiss gene-editing specialist CRISPR Therapeutics (Nasdaq: CRSP) and San Diego, USA-based Sirius Therapeutics, which is ...

The U.S. military is interested in ‘super spiders’ capable of producing silk with extraordinary features. Don’t worry—it ...

Crispr Therapeutics said it is partnering with Sirius Therapeutics to develop and commercialize SRSD107, a small interfering RNA therapy to treat thromboembolic disorders. Under the agreement, Crispr ...

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

A team of researchers from University of Bayreuth have used genetic modification on common house spiders to study the underrepresented organism and produce functionable spider silk protein. Scroll to ...

The most well-known is CRISPR-Cas9, adapted for human use as ... Thanks to an unusually complex molecular structure, this protein can deplete a metabolite essential for cellular function.

The most well-known is CRISPR-Cas9, adapted for human use as ... Thanks to an unusually complex molecular structure, this protein can deplete a metabolite essential for cellular function.

CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA ...